1016 related articles for article (PubMed ID: 16094107)
1. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
2. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
3. Planned post-chemoradiation neck dissection: significance of radiation dose.
Stenson KM; Huo D; Blair E; Cohen EE; Argiris A; Haraf DJ; Vokes EE
Laryngoscope; 2006 Jan; 116(1):33-6. PubMed ID: 16481805
[TBL] [Abstract][Full Text] [Related]
4. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with nonparticipation in one-year quality-of-life assessment in patients with head and neck squamous cell carcinoma.
Gourin CG; Kaboli KC; Boyce BJ; Burkhead LM
Laryngoscope; 2010 Jul; 120(7):1435-43. PubMed ID: 20564472
[TBL] [Abstract][Full Text] [Related]
6. Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country.
Vartanian JG; Carvalho AL; Yueh B; Priante AV; de Melo RL; Correia LM; Köhler HF; Toyota J; Kowalski IS; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1209-13. PubMed ID: 15492171
[TBL] [Abstract][Full Text] [Related]
7. Influences and predictors of long-term quality of life in head and neck cancer survivors.
El-Deiry MW; Futran ND; McDowell JA; Weymuller EA; Yueh B
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):380-4. PubMed ID: 19380361
[TBL] [Abstract][Full Text] [Related]
8. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
[TBL] [Abstract][Full Text] [Related]
9. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
10. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
12. Psychological coping style versus disease extent, tumour treatment and quality of life in successfully treated head and neck squamous cell carcinoma patients.
Aarstad AK; Aarstad HJ; Bru E; Olofsson J
Clin Otolaryngol; 2005 Dec; 30(6):530-8. PubMed ID: 16402979
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
14. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
16. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
17. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy.
Doweck I; Denys D; Robbins KT
Laryngoscope; 2002 Oct; 112(10):1742-9. PubMed ID: 12368607
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in elderly patients with head and neck cancer one year after diagnosis.
Derks W; de Leeuw RJ; Hordijk GJ; Winnubst JA
Head Neck; 2004 Dec; 26(12):1045-52. PubMed ID: 15459917
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
20. Selective neck dissection following adjuvant therapy for advanced head and neck cancer.
Mukhija V; Gupta S; Jacobson AS; Eloy JA; Genden EM
Head Neck; 2009 Feb; 31(2):183-8. PubMed ID: 19031407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
